Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Central Asia Tbk (BBCA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Bank Central Asia TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank Central Asia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Bank Central Asia Tbk trades at Rp6,250 (market cap 774.97T, 16.42M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp162 (market cap 635.95B, 218.3K 24h volume). The key difference: Bank Central Asia Tbk is far larger — about 1218.6× UBC Medical Indonesia Tbk.'s market cap, and Bank Central Asia Tbk is more actively traded (16.42M versus 218.3K). Which is the better fit depends on your goals.

BBCALABS
Market Cap
774.97T635.95B
Volume
16.42M218.3K
Lot
164.24K2.18K
Turnover
103.37B35.51M
Average Price
6,294.05162.69
Value
103.37B35.51M
Indicative Equilibrium Price
6,350163
Indicative Equilibrium Volume
2.2M16

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BBCA
View details
LABS
View details

About Bank Central Asia Tbk

PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.

Read more on BBCA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS